SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the March 2022 quarter moved down to Rs. 582.31 millions as compared to Rs. 655.42 millions during the year-ago period.The Net Profit of the company slipped to Rs. 47.57 millions from Rs. 69.49 millions, a decline of -31.54% on QoQ basis.Operating Profit reported a sharp decline to 75.97 millions from 121.44 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 582.31 655.42 -11.15 2196.63 2448.05 -10.27 2196.63 2448.05 -10.27
Other Income 57.02 37.32 52.79 119.93 71.41 67.95 119.93 71.41 67.95
PBIDT 75.97 121.44 -37.44 314.56 449.80 -30.07 314.56 449.80 -30.07
Interest 8.93 1.56 472.44 13.55 2.71 400.00 13.55 2.71 400.00
PBDT 66.93 120.18 -44.31 301.25 447.39 -32.67 301.25 447.39 -32.67
Depreciation 10.12 10.50 -3.62 39.48 40.35 -2.16 39.48 40.35 -2.16
PBT 56.81 109.68 -48.20 261.77 407.04 -35.69 261.77 407.04 -35.69
TAX 9.24 40.19 -77.01 63.86 115.32 -44.62 63.86 115.32 -44.62
Deferred Tax -1.10 1.28 -185.94 1.40 2.31 -39.39 1.40 2.31 -39.39
PAT 47.57 69.49 -31.54 197.91 291.72 -32.16 197.91 291.72 -32.16
Equity 862.45 789.95 9.18 862.45 789.95 9.18 862.45 789.95 9.18
PBIDTM(%) 13.05 18.53 -29.59 14.32 18.37 -22.06 14.32 18.37 -22.06

Syncom Formulations Share Price

14.45 -0.03 (-0.21%)
16-Jun-2026 10:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.40
Dr. Reddys Lab 1284.10
Cipla 1387.50
Zydus Lifesciences 1086.00
Lupin 2268.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: